temozolomide has been researched along with Brain Ventricular Neoplasms in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the U87 intracerebral glioma model, within the first day of administration of cediranib, the intratumoral concentrations of TMZ in tumor ECF were slightly, but not statistically significantly, increased when compared to the treatment of TMZ alone with radiographic evidence of a normalized BBB." | 7.79 | Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model. ( Blakeley, JO; Brem, H; Grossman, R; Khan, U; Kim, E; Pathak, AP; Rudek, MA; Tyler, B; Zadnik, P, 2013) |
| "Paclitaxel is an antineoplastic agent that is used in the treatment of a variety of solid tumors." | 5.35 | Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma. ( Fangusaro, J; Finlay, J; Rook, J; Rosser, T, 2008) |
| "In the U87 intracerebral glioma model, within the first day of administration of cediranib, the intratumoral concentrations of TMZ in tumor ECF were slightly, but not statistically significantly, increased when compared to the treatment of TMZ alone with radiographic evidence of a normalized BBB." | 3.79 | Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model. ( Blakeley, JO; Brem, H; Grossman, R; Khan, U; Kim, E; Pathak, AP; Rudek, MA; Tyler, B; Zadnik, P, 2013) |
| "Paclitaxel is an antineoplastic agent that is used in the treatment of a variety of solid tumors." | 1.35 | Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma. ( Fangusaro, J; Finlay, J; Rook, J; Rosser, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grossman, R | 1 |
| Tyler, B | 1 |
| Rudek, MA | 1 |
| Kim, E | 1 |
| Zadnik, P | 1 |
| Khan, U | 1 |
| Blakeley, JO | 1 |
| Pathak, AP | 1 |
| Brem, H | 1 |
| Yano, H | 1 |
| Nakayama, N | 1 |
| Hirose, Y | 1 |
| Ohe, N | 1 |
| Shinoda, J | 1 |
| Yoshimura, S | 1 |
| Iwama, T | 1 |
| Enting, RH | 1 |
| van der Graaf, WT | 1 |
| Kros, JM | 1 |
| Heesters, M | 1 |
| Metzemaekers, J | 1 |
| den Dunnen, W | 1 |
| Rook, J | 1 |
| Rosser, T | 1 |
| Fangusaro, J | 1 |
| Finlay, J | 1 |
1 review available for temozolomide and Brain Ventricular Neoplasms
| Article | Year |
|---|---|
Intraventricular glioneuronal tumor with disseminated lesions at diagnosis--a case report.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Cerebral Ventricle Neoplasms; Cerebral Ventric | 2011 |
3 other studies available for temozolomide and Brain Ventricular Neoplasms
| Article | Year |
|---|---|
Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineop | 2013 |
Radiotherapy plus concomitant and adjuvant temozolomide for leptomeningeal pilomyxoid astrocytoma: a case study.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Cerebral Ventricle Neoplasms; Chemotherapy, A | 2006 |
Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain | 2008 |